Lebanon vamc begins covid-19 vaccine distribution with moderna | va lebanon health care | veterans affairs

Lebanon , PA — Lebanon VA Medical Center (VAMC) will begin COVID-19 vaccination with the Moderna COVID-19 vaccine today following the U.S. Food and Drug Administration’s Emergency Use

Authorization for this vaccine. “Lebanon VA is eager to offer the Moderna COVID-19 vaccine to health care personnel and Veteran community living center residents,” said Stuart A. Roop, MD,

Lebanon VA Chief of Staff. “Receiving the vaccine is like having hope delivered. As vaccine supplies increase, our ultimate goal is to offer COVID-19 vaccination to all Veterans and

employees who want to be vaccinated.” Lebanon VAMC is one of 113 VA Medical Centers across the country to receive the first limited supply of the Moderna COVID-19 vaccine. Sites were

identified based on need for the vaccine according to CDC’s 1A prioritization and capacity to store the vaccine at -20◦C. The Moderna COVID-19 vaccine was 94 percent effective in clinical

trials in preventing COVID-19 disease. The vaccine is administered in two doses, 28 days apart. The side effects appear similar to those of other vaccines and are short-lived. Thirty-seven

medical centers began offering the Pfizer-BioNTech COVID-19 vaccine to health care personnel and Veterans Dec 14. Fifteen additional VA facilities will receive an allocation of

Pfizer-BioNTech COVID-19 vaccine the week of December 21. Even after receiving COVID-19 vaccination, employees and Veterans should continue wearing face coverings, practicing physical

distancing and washing hands often. As vaccines become available for more groups of Veterans, VA care teams will reach out to eligible Veterans to schedule vaccinations. There is no need to

preregister or come to a facility to sign up. Veterans can get up-to-date information on VA’s VA COVID-19 vaccine webpage, which launched on December 11, 2020, and sign up to receive regular

updates on the vaccine on the VA’s Stay Informed page. For more information, please contact Douglas Etter at [email protected] or 717-228-6079.